Сhitotriosidase activity in prediction of poor prognosis in COVID-19 hospitalized patients
- Authors: Schelkanovtseva E.S.1, Mironova O.I.1, Solovev K.A.1, Berestova E.A.1, Balakhonov A.A.1, Nagornov I.O.2, Fomin V.V.1, Panferov A.S.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Bochkov Research Centre for Medical Genetics
- Issue: Vol 25, No 3 (2023): Otorhinolaryngology and pulmonology
- Pages: 163-167
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/131649
- DOI: https://doi.org/10.26442/20751753.2023.3.202093
- ID: 131649
Cite item
Full Text
Abstract
Background. The identification of early predictors of poor outcomes of new coronavirus infection is necessary for optimizing patient management algorithms for hospitalized patients with COVID-19.
Aim. To study the role of chitotriosidase activity as a marker of unfavorable outcomes in COVID-19 hospitalized patients.
Materials and methods. The prospective observational single-center study included 347 patients with COVID-19 hospitalized in university clinic. In addition to the standard laboratory analysis (complete blood count, C-reactive protein, ferritin, creatinine, international normalized ratio, etc.) the blood serum chitotriosidase activity was determined at all the patients on admission. Primary endpoints were mortality from all causes and performing invasive ventilation (IV) and/or non-invasive ventilation (NIV). This study was approved by the Local Ethics Committee №12-21 (Clinical Trial Registry: NCT04752085).
Results. A total of 347 patients were enrolled in this study (average age 66 years, females 182 – 52.5%), 30 patients (8.6%) died during the hospitalization, 39 (11.2%) performed IV or NIV. Along with age more than 65 (odds ratio – OR 10.81, 95% confidence interval – CI 2.64–44.22) and Neutrophil-Lymphocyte Ratio higher than 7 (OR 15.89, 95% CI 3.09–81.65) chitotriosidase activity higher than 170 ng/hr/ml (OR 4.23, 95% CI 1.45–12.35) were independent predictors of mortality during hospitalization. Neutrophil-Lymphocyte Ratio higher than 5.6 (OR 11.22, 95% CI 2.37–53,1) and сhitotriosidase activity higher than 151 ng/hr/ml (OR 3.17, 95% CI 1.31–7.67) have been evaluated as predictors of performing IV/NIV.
Conclusion. Chitotriosidase level more than 151 nmol/h/mL could be considered as an early predictor of severity and poor prognosis in hospitalized patients with COVID-19.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Ekaterina S. Schelkanovtseva
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: mar-shhelkanovceva@yandex.ru
ORCID iD: 0000-0001-9098-4098
Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowOlga Iu. Mironova
Sechenov First Moscow State Medical University (Sechenov University)
Email: mar-shhelkanovceva@yandex.ru
ORCID iD: 0000-0002-5820-1759
D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowKirill A. Solovev
Sechenov First Moscow State Medical University (Sechenov University)
Email: solovev_k_a@student.sechenov.ru
ORCID iD: 0000-0002-2062-2232
Student, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowElizaveta A. Berestova
Sechenov First Moscow State Medical University (Sechenov University)
Email: e-berestova@list.ru
ORCID iD: 0000-0002-0908-8040
Student, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowAlexander A. Balakhonov
Sechenov First Moscow State Medical University (Sechenov University)
Email: mar-shhelkanovceva@yandex.ru
ORCID iD: 0000-0002-1166-9856
Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowIlya O. Nagornov
Bochkov Research Centre for Medical Genetics
Email: mar-shhelkanovceva@yandex.ru
ORCID iD: 0000-0001-9368-1594
Laboratory Geneticist, Bochkov Research Centre for Medical Genetics
Russian Federation, MoscowVictor V. Fomin
Sechenov First Moscow State Medical University (Sechenov University)
Email: mar-shhelkanovceva@yandex.ru
ORCID iD: 0000-0002-2682-4417
D. Sci. (Med.)., Prof., Corr. Memb. RAS, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowAlexandr S. Panferov
Sechenov First Moscow State Medical University (Sechenov University)
Email: mar-shhelkanovceva@yandex.ru
ORCID iD: 0000-0002-4324-7615
Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowReferences
- Профилактика, диагностика и лечение новой коронавирусной инфекции 2019-nCoV. Временные методические рекомендации Министерства здравоохранения Российской Федерации. 2021. Версия 12 [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii 2019-nCoV. Vremennye metodicheskie rekomendatsii Ministerstva zdravookhraneniia Rossiiskoi Federatsii. 2021. Versiia 12 (in Russian)].
- Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Investigat. 1994;93(3):1288-92. doi: 10.1172/JCI117084
- Malaguarnera L, Di Rosa M, Zambito AM, et al. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut. 2006;55(9):1313-20. doi: 10.1136/gut.2005.075697
- Профилактика, диагностика и лечение новой коронавирусной инфекции 2019-nCoV. Временные методические рекомендации Министерства здравоохранения Российской Федерации. 2020. Версия 9 [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii 2019-nCoV. Vremennye metodicheskie rekomendatsii Ministerstva zdravookhraneniia Rossiiskoi Federatsii. 2020. Versiia 9 (in Russian)].
- Kimura Y, Nakai Y, Shin J, et al. Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach. Nature. 2021;11:20638. doi: 10.1038/s41598-021-98253-9
- Fusetti F, Pijning T, Kalk KH, et al. Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem. 2003;278(39):37753-60. doi: 10.1074/jbc.M303137200
- Hakala BE, White C, Recklies AD, et al. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem. 1993;268(34):25803-10.
- Kzhyshkowska J, Gratchev A, Goerdt S, et al. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights. 2007;2:128-46.
- Gooday GW. Aggressive and defensive roles for chitinases. Exs. 1999;87:157-69. doi: 10.1007/978-3-0348-8757-1_11
- Elmonem MA, van den Heuvel LP, Levtchenko EN, et al. Immunomodulatory Effects of Chitotriosidase Enzyme. Enzyme Res. 2016;2016:2682680. doi: 10.1155/2016/2682680
- James AJ, Reinius LE, Verhoek M, et al. The chitinase proteins YKL-40 and chitotriosidase are increased in both asthma and COPD. Am J Respir Crit Care Med. 2015;193(2). doi: 10.1164/rccm.201504-0760OC
- Di Rosa M, Mangano K, De Gregorio C, et al. Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. Hepatol Res. 2013;43(3):267-75. doi: 10.1111/j.1872-034X.2012.01063.x
- Skvortsov A, Balakhonov A, Panferov A, et al. Chitotriosidase Activity in Lung Injury Associated with Coronavirus Disease 2019 (COVID-19). Am J Respir Crit Care Med. 2021;203(9):A1288.
- Renkema GH, Boot RG, Strijland A, et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Euro J Biochem. 1997;244(2):279-85. doi: 10.1111/j.1432-1033.1997.00279.x
- Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827
- de Jager CP, Wever PC, Gemen EF, et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One. 2012;7:e46561.
- Russell CD, Parajuli A, Gale HJ, et al. The Utility of Peripheral Blood Leucocyte Ratios as Biomarkers in Infectious Diseases: A Systematic Review and Meta-Analysis. J Infect. 2019;78(5):339-48. doi: 10.1016/j.jinf.2019.02.006
- Li X, Liu C, Mao Z, et al. Predictive Values of Neutrophil-to-Lymphocyte Ratio on Disease Severity and Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Crit Care. 2020;24(1):647. doi: 10.1186/s13054-020-03374-8
- Eslamijouybari M, Heydari K, Maleki I, et al. Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship With Disease Prognosis. Caspian J Intern Med. 2020;11(Suppl. 1):531-5. doi: 10.22088/cjim.11.0.531
- Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel systemic inflammation markers to predict COVID-19 prognosis. Front Immunol. 2021;12:741061. doi: 10.3389/fimmu.2021.741061